ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Innovent Biologics Inc (PK)

Innovent Biologics Inc (PK) (IVBXF)

9.96
0.00
(0.00%)
終了 6月22日 5:00AM

Innovent Biologics Inc (PK) (IVBXF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
9.96
( - )
買値
9.01
売値
10.01
出来高
-
0.00 日の範囲 0.00
9.10 52 週間の範囲 15.12
時価総額
前日終値
9.96
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 13,258,095
発行済株式数
1,738,237,233
配当利回り
PER
139.75
1 株当たり利益 (EPS)
0.47
歳入
13.04B
純利益
813.57M

Innovent Biologics Inc (PK) について

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal ant... Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People’s Republic of China. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Suzhou, China
設立
2026
Innovent Biologics Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker IVBXF. The last closing price for Innovent Biologics (PK) was US$9.96. Over the last year, Innovent Biologics (PK) shares have traded in a share price range of US$ 9.10 to US$ 15.12.

Innovent Biologics (PK) currently has 1,738,237,233 shares in issue. The market capitalisation of Innovent Biologics (PK) is US$17.31 billion. Innovent Biologics (PK) has a price to earnings ratio (PE ratio) of 139.75.

IVBXF 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.02520.2536538229259.934810.0529.1322949.63366994CS
4-0.11-1.0923535253210.0711.3349.1976411.04889235CS
12-0.04-0.41012.359.1828611.02689149CS
26-0.23-2.2571148184510.1912.359.1891210.44255944CS
52-0.44-4.2307692307710.415.129.12919611.56294537CS
1565.97149.624060153.9915.123.55660386.29565459CS
260-0.54-5.1428571428610.515.122.29497596.37515053CS

IVBXF - Frequently Asked Questions (FAQ)

What is the current Innovent Biologics Inc (PK) share price?
The current share price of Innovent Biologics Inc (PK) is US$ 9.96
How many Innovent Biologics Inc (PK) shares are in issue?
Innovent Biologics Inc (PK) has 1,738,237,233 shares in issue
What is the market cap of Innovent Biologics Inc (PK)?
The market capitalisation of Innovent Biologics Inc (PK) is USD 17.31B
What is the 1 year trading range for Innovent Biologics Inc (PK) share price?
Innovent Biologics Inc (PK) has traded in the range of US$ 9.10 to US$ 15.12 during the past year
What is the PE ratio of Innovent Biologics Inc (PK)?
The price to earnings ratio of Innovent Biologics Inc (PK) is 139.75
What is the cash to sales ratio of Innovent Biologics Inc (PK)?
The cash to sales ratio of Innovent Biologics Inc (PK) is 8.75
What is the registered address of Innovent Biologics Inc (PK)?
The registered address for Innovent Biologics Inc (PK) is 168 Dongping Street, Suzhou, Jiangsu Province, 215123
What is the Innovent Biologics Inc (PK) website address?
The website address for Innovent Biologics Inc (PK) is www.innoventbio.com
Which industry sector does Innovent Biologics Inc (PK) operate in?
Innovent Biologics Inc (PK) operates in the Biotechnology & Life Sciences sector

IVBXF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード